Intellia Therapeutics Overview
Intellia Therapeutics Target Price
Analysts' 12-month price predictions for NTLA.
Get informed when a big investor buys or sells
+ FollowShare Price
$17.56
Average Target Price
$26.29
49.7% upside
49.7% upside7 analysts in the last 4 months
High: $49 | Low: $13
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-15 | New Street | $25 | 42.4% upside |  |
| 2026-05-13 | Bernstein | $17 |  3.2% downside | |
| 2026-05-12 | Canaccord Genuity | $49 | 179% upside | |
| 2026-04-27 | Chardan Capital | $30 | 70.8% upside | |
| 2026-04-27 | Robert W. BairdJack Allen | $13 | 26% downside | |
| 2026-04-27 | Morgan Stanley | $15 | 14.6% downside | |
| 2026-04-27 | Leerink Partners | $35 | 99.3% upside | |
| 2026-01-28 | KeyBanc | $25 | 42.4% upside | |
| 2026-01-27 | Robert W. BairdJack Allen | $7 | 60.1% downside | |
| 2025-11-11 | Evercore ISI | $8 | 54.4% downside | |
| 2025-11-10 | Truist Financial | $14 | 20.3% downside | |
| 2025-11-07 | Oppenheimer | $27 | 53.8% upside | |
| 2025-10-30 | H.C. WainwrightMitchell Kapoor | $18 | 2.5% upside | |
| 2025-10-30 | WedbushDavid Nierengarten | $9 | 48.7% downside | |
| 2025-10-30 | Robert W. BairdJack Allen | $9 | 48.7% downside | |
| 2025-10-28 | JMP Securities | $29 | 65.1% upside | |
| 2025-10-28 | Bernstein | $14.5 | 17.4% downside | |
| 2025-10-28 | BarclaysGena Wang | $24 | 36.7% upside | |
| 2025-10-28 | Tudor PickeringWilliam Pickering | $14.5 | 17.4% downside | |
| 2025-10-28 | RBC CapitalLuca Issi | $14 | 20.3% downside | |
| 2025-10-27 | Chardan Capital | $48 | 173.3% upside | |
| 2025-10-27 | H.C. WainwrightMitchell Kapoor | $25 | 42.4% upside | |
| 2025-10-06 | JMP SecuritiesSilvan Tuerkcan | $33 | 87.9% upside | |
| 2025-08-13 | GuggenheimDebjit Chattopadhyay | $14 | 20.3% downside | |
| 2025-02-28 | Goldman Sachs | $9 | 48.7% downside | |
| 2025-02-28 | Barclays | $26 | 48.1% upside | |
| 2024-11-11 | OppenheimerJay Olson | $60 | 241.7% upside | |
| 2024-10-24 | Robert W. BairdJack Allen | $18 | 2.5% upside | |
| 2024-08-09 | RBC CapitalLuca Issi | $54 | 207.5% upside | |
| 2024-06-24 | Stifel NicolausDae Gon Ha | $80 | 355.6% upside | |
| 2024-06-24 | Robert W. BairdJack Allen | $24 | 36.7% upside | |
| 2024-05-10 | BMO CapitalKostas Biliouris | $70 | 298.6% upside | |
| 2023-02-01 | Cantor Fitzgerald | $67 | 281.5% upside | |
| 2023-01-04 | Wells Fargo | $120 | 583.4% upside | |
| 2022-12-06 | Credit Suisse | $88 | 401.1% upside | |
| 2022-12-02 | Leerink Partners | $86 | 389.7% upside | |
| 2022-11-15 | Chardan Capital | $129 | 634.6% upside | |
| 2022-08-05 | Leerink Partners | $152 | 765.6% upside | |
| 2022-08-05 | Chardan Capital | $146 | 731.4% upside | |
| 2022-06-16 | BMO CapitalKostas Biliouris | $54 | 207.5% upside | |
| 2022-05-09 | JMP Securities | $110 | 526.4% upside | |
| 2022-05-09 | Raymond JamesSteven Seedhouse | $105 | 497.9% upside | |
| 2022-05-06 | Credit Suisse | $98 | 458.1% upside | |
| 2022-02-24 | RBC CapitalLuca Issi | $150 | 754.2% upside | |
| 2022-02-18 | William BlairRaju Prasad | $144 | 720% upside | |
| 2022-02-15 | Truist FinancialJoon Lee | $160 | 811.2% upside | |
| 2022-02-03 | Piper SandlerSwapnil Malekar | $171 | 873.8% upside | |
| 2022-02-03 | WedbushDavid Nierengarten | $108 | 515% upside | |
| 2021-11-16 | Roth CapitalAnthony Butler | $180 | 925.1% upside | |
| 2021-08-06 | Goldman SachsSalveen Richter | $252 | 1335.1% upside | |